Colocalization of Somatostatin and Epidermal Growth Factor Receptors in Breast Cancer Cells
Author Information
Author(s): Heather L Watt, Ujendra Kumar
Primary Institution: McGill University
Hypothesis
Are somatostatin receptors (SSTRs) and epidermal growth factor receptors (ErbBs) coexpressed in breast cancer cells?
Conclusion
The study found significant correlations in the expression of SSTRs and ErbBs in breast cancer cells, which may explain the poor response to endocrine therapy in ER-cancer.
Supporting Evidence
- All five SSTRs and four ErbBs were variably expressed in both MCF-7 and MDA-MB-231 cells.
- SSTR1 and SSTR4 were more highly expressed in MCF-7 cells than in MDA-MB-231 cells.
- Colocalization of SSTRs with ErbBs was significantly higher in MCF-7 cells compared to MDA-MB-231 cells.
Takeaway
This study looked at how two types of receptors in breast cancer cells work together, which might help us understand why some treatments don't work well.
Methodology
The study used semi-quantitative RT-PCR and western blot analysis to measure the expression of SSTRs and ErbBs in MCF-7 and MDA-MB-231 breast cancer cell lines.
Limitations
The study's findings may not fully represent the behavior of SSTRs and ErbBs in solid tumors compared to cultured cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website